Actively Recruiting
Post-market Clinical Follow-up (PMCF) Study of Safety and Performance of 502-01 AnGelHA 2
Led by Glyance · Updated on 2026-04-15
87
Participants Needed
1
Research Sites
56 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Post-market clinical follow-up (PMCF) investigation to evaluate the performance and safety of AnGelHA 2 filler for the correction of moderate to severe wrinkles and folds and facial contour remodeling, in a routine clinical setting.
CONDITIONS
Official Title
Post-market Clinical Follow-up (PMCF) Study of Safety and Performance of 502-01 AnGelHA 2
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Men or women of any race, 18 years of age or older
- Able to read, understand and sign informed consent
You will not qualify if you...
- Pregnant or lactating women (contraindications as per IFU)
- Received dermal filler injections in the six months before the study
- Previously treated with semi-permanent or permanent filler in the intended injection area
- Having a skin disorder, inflammation, or infection near the treatment area
- Known allergy to lidocaine, lidocaine HCl, or hyaluronic acid
- Uncontrolled metabolic or endocrine disease, anaphylaxis, severe allergies, or immune disorders
- Undergoing or planning peeling, laser, or ultrasound treatments within 3 weeks before or after injection
- Received anticoagulants, anti-platelet, thrombolytics, NSAIDs, or other blood-thinning substances within one week before treatment without wash-out period
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Glyance Ltd
Lod, Israel, Israel, 7152026
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here